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Abstract
Background: Despite extensive research, the debate continues as to the optimal way of guiding intraoperative and
postoperative fluid therapy. In 2009 we changed our institutional guideline for perioperative fluid therapy in
patients undergoing extrapleural pneumonectomy (EPP) and implemented the use of central venous oxygen
saturation and intended low urine output to guide therapy in the early postoperative period. Here we evaluate the
consequences of our changes.
Methods: Retrospective, observational study of 30 consecutive patients undergoing EPP; 18 who had surgery
before and 12 who had surgery after the changes. Data were collected from patient files and from institutional
databases. Outcome measures included: Volumes of administered fluids, fluid balances, length of stays and
postoperative complications. Dichotomous variables were compared with Fisher’s exact test, whereas continuous
variables were compared with Student’s unpaired t-test or the Wilcoxon Two-Sample Test depending on the
distribution of data.
Results: The applied changes significantly reduced the volumes of administered fluids, both in the intraoperative
(p = 0.01) and the postoperative period (p = 0.04), without increasing the incidence of postoperative complications.
Mean length of stay in the intensive care unit (LOSI) was reduced from three to one day (p = 0.04) after the
changes.
Conclusion: The use of clinical parameters to balance fluid restriction and a sufficient circulation in patients
undergoing EPP was associated with a reduction in mean LOSI without increasing the incidence of postoperative
complications. Due to methodological limitations these results are only hypothesis generating.
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Background
With morbidity and mortality rates of 22–82 % and 3–34 %
respectively [1, 2], extrapleural pneumonectomy (EPP)
is considered a high-risk procedure. Acute Respiratory
Distress Syndrome (ARDS) [3] is one of several well-
known complications to EPP, and since excessive fluid
administration may play a role in the development of
ARDS [4], perioperative fluid administration tends to be
restrictive in these procedures. However, the fluid and
inopressor therapy has historically been quite variable
in patients undergoing EPP, which were why we in August
2009 changed our institutional guideline for perioperative
fluid therapy in these patients. The purpose was to opti-
mise the perioperative treatment by balancing restrictive
fluid administration against an adequate circulation to en-
sure sufficient oxygen supply. The changes included steps
to restrict intraoperative fluid administration and the im-
plementation of a clinically based algorithm of balanced
goal-directed therapy (BGDT) to use postoperatively in
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the intensive care unit (ICU). The objective of this
study was to assess the consequences of our changes in
terms of volumes and balances of administered fluids,
incidences of postoperative complications, length of
stay in the ICU (LOSI) and length of stay in the hos-
pital (LOS).
Methods
Ethics, study design, settings and participants
This study was considered a quality assurance process
for which reason approval by the regional ethical com-
mittee was not required. Collection of data was ap-
proved by the Danish Data Protection Agency (J.nr:
2007-58-0015).
This is a retrospective, observational study, including
30 consecutive patients who underwent EPP for malig-
nant pleural mesothelioma between August 2007 and
January 2012 at the Copenhagen University Hospital,
Rigshospitalet, Denmark. The changed guideline was in-
troduced in August 2009, and 18 patients underwent
surgery before (before group), while 12 patients under-
went surgery after the changes were implemented (after
group). Before surgery, all patients received 3–6 series of
pemtrexed and cisplatin chemotherapy and afterwards
operability was confirmed by a positron emission tomog-
raphy/computed tomography scan. A mediastinoscopy
was performed one week before EPP was scheduled, and
EPP was offered in case of: unilateral cancer without
chest wall penetration or infiltrated lymph nodes in the
mediastinum, epithelial type of cancer, pneumonectomy
allowed by pulmonary function, no major cardiac events
in the past, a left ventricular ejection fraction > 40 % and
age < 70 years.
The patients were anaesthetised using propofol and
remifentanil, and all patients had a left-sided, double-
lumen endotracheal tube, an arterial line and a central
venous line inserted. During one-lung ventilation,
pressure-controlled ventilation was used with the frac-
tion of oxygen reduced to the lowest level keeping arter-
ial saturation above 90 %. All patients were extubated in
the operating room and transferred to the ICU, and
postoperative analgesia was achieved by a thoracic epi-
dural catheter. The surgery was performed by the same
experienced surgeon through a posterolateral thoracot-
omy and the same ICU discharge criteria were utilised
during the study period [5].
Changes in standard therapy
A number of changes were made to balance restrictive
fluid administration and adequate oxygen supply. Fluid
restriction during surgery was achieved by simple proced-
ural changes, as outlined below, whereas postoperative
fluid restriction was reached through the introduction of
BGDT.
Changes applied in the intraoperative period:
1. Hypotension related to the induction of anaesthe-
sia or to epidural analgesia was treated with ephedrine
and/or phenylephrine rather than intravenous fluid
administration.
2. Insensible perspiration was reduced from 5 ml * kg−1
* hour (h)−1 to 1 ml * kg−1 * h−1, and volumes of intra-
venously administered medicine was included in the
calculation of the intraoperative fluid balance, which
were intended between 0 and minus 500 ml.
Change applied in the postoperative period:
1. BGDT was implemented to achieve fluid restriction
and still maintain adequate oxygen delivery. The intention
was to guide therapy by easily measured clinical variables.
The interventional thresholds were urine output of 0.5 ml *
kg−1 * h−1 and central venous oxygen saturation (ScvO2)
of 60 % (Fig. 1).
Changes applied in the intra- and postoperative periods:
1. The recommended colloid of choice was changed
from dextran (Macrodex®, MEDA, Solna Sweden) to
hydroxyethyl starch (Voluven®, Fresenius Kabi AG,
Bad Homburg, Germany) as the maximal volume of
Voluven® to be administered in 24 h is twice that of
Macrodex®.
2. It was pointed out to all relevant personnel that the
transfusion trigger for red blood cells is a haemoglobin
Fig. 1 Schematic model of balanced goal-directed therapy used in the postoperative period after extrapleural pneumonectomy. #In the case of
total anuria in combination with ScvO2≥ 60 % kidney failure should be suspected. ScvO2 Central venous oxygen saturation; ml millilitres; kg kilo-
gram (ideal body weight); h hour; IV intravenous
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concentration of 7.5 g * dl−1 in the case of no bleeding
or controlled bleeding [6].
Data collection
Data on age, gender, weight, height, smoking status, co-
morbidity, classification according to the American Society
of Anesthesiologists (ASA), plasma creatinine preopera-
tively and on the first and third postoperative day (POD),
values of ScvO2, plasma lactate, administration of ino-
tropic drugs and cumulated urine output on the day of
surgery, administered volumes of fluid (including blood
products), and fluid balances were collected from the pa-
tients’ files. In all cases with LOSI > 1 day, we reviewed the
patient’s medical chart to determine the main reason for
the continued stay in the ICU. Preoperative pulmonary
status (forced expiratory volume in one second (FEV1)
and diffusion capacity for carbon monoxide (DLCO)),
tumour stage, resection side, duration of surgery, intra-
operative bleeding, LOSI, LOS and postoperative com-
plications were collected from institutional databases.
Measurements of ScvO2 and plasma lactate levels were
obtained regularly. Chest x-rays from the first POD
were evaluated by a radiologist for signs of pulmonary
stasis. Fluid balances were calculated as the sum of all
fluids given, subtracted all deficits such as perspiration,
urine output, output in drain(s) and other losses if rele-
vant. If a patient was readmitted to the ICU < 24 h after
discharge, it was considered a continued admission. LOSI
and LOS were both counted from the day of surgery. Post-
operative complications were defined as complications be-
fore discharge from the hospital.
Statistics
Dichotomous variables are given as counts and percent-
ages. Continuous variables are given as means with 95 %
confidence intervals or as medians and ranges in case of
non-normally distributed data. Dichotomous variables
were compared with Fisher’s exact test, whereas continuous
variables were compared with Student’s unpaired t-test or
the Wilcoxon Two-Sample Test depending on the distribu-
tion of data. All tests were 2-sided, and a significance
level of 5 % was used. Data analyses were performed in
the Statistical Analysis System version 9.1.3 (SAS Institute
Inc., Cary, NC).
Results
The two groups were comparable regarding basic char-
acteristics (Table 1). Volumes of administered fluids and
fluid balances are given in Table 2, and data from the
intra- and postoperative periods are given in Table 3.
During surgery, 14 patients (78 %) in the before group
and five patients (42 %) in the after group had blood
transfusions (p = 0.06). Postoperatively in the ICU eight
patients (44 %) in the before group and one patient
(8 %) in the after group received blood products (p =
0.05). We found no differences in the incidence of car-
diac, respiratory, gastrointestinal or renal complications
between the two groups (Table 3). Patients in the after
group had significantly shorter LOSI (p = 0.04), and a
tendency towards shorter LOS (p = 0.09) (Table 3). Six
patients from the before group had LOSI > 1 day; five
due to a continued need for inotropic support and one
who developed postoperative atrial fibrillation. None of
the patients in the after group had LOSI > 1 day
(Table 3). One patient from the before group was dis-
charged from the ICU on the second postoperative day,
but readmitted within 24 h. This patient needed ventila-
tor treatment for 19 days. Also, one patient from the be-
fore group required continuous renal replacement
therapy for 24 h.
Discussion
The development of ARDS as characterised in the Berlin
Definition from 2011 [3] is a well-known complication
to pulmonary resection, and to pneumonectomy in par-
ticular. In 1984, Zeldin [7] proposed that excessive fluid
administration was the cause of pulmonary oedema after
pneumonectomy. Since then several mechanisms have
been proposed to take part in the development of what
may be defined as ARDS after pneumonectomy, and ex-
cessive fluid administration might just be one of several
contributory factors [4].
In 2002, Møller et al. [8] showed that an excess fluid
balance of more than 4 l during surgery was associated
with a higher risk of postoperative complications after
pneumonectomy and in 2010, Marret et al. [9] found
that liberal fluid administration during surgery was a risk
factor for major complications after pneumonectomy.
Furthermore, Suehiro et al. [10] found that high fluid in-
fusion volumes during pneumonectomy were a risk fac-
tor for developing postoperative right-sided heart failure.
However, even though fluid restriction seems to be an
important factor in reducing complications after pneu-
monectomy, it may compromise cardiac output and
ultimately lead to inadequate oxygen delivery. As re-
cently discussed [11], the use of haemodynamic moni-
toring by devices such as transesophageal Doppler,
PiCCO etc. may prove useful for guiding perioperative
fluid therapy in pulmonary resection surgery, but still
further research is needed in this field. However, goal-
directed therapy using measurements of cardiac output
alone, often leads to higher volumes of administered
fluid compared to conventional therapy [12], and there-
fore the debate continues as to the optimal dose of fluid
and which haemodynamic goal and/or vasopressor are
best [13].
According to the Fick equation mixed venous oxygen
saturation (SvO2) is related to the fraction of delivered
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oxygen that is consumed by the tissues, and a reduced
SvO2 is thought to reflect elevated oxygen extraction,
compensating for a reduced cardiac output [14]. Since
ScvO2 has been shown to correlate with SvO2 [15], the
former was used to avoid insertion of a pulmonary artery
catheter. In sepsis treatment, a ScvO2 > 70 % is widely
used and it has been suggested that normovolemia in
the supine position is reached when fluid administration
results in a ScvO2 higher than 65 % [16]. Furthermore,
it has been suggested that perioperative mean values of
ScvO2 < 71–73 % are correlated to an increased risk of
postoperative complications - predominantly infections -
after high-risk abdominal surgery [17, 18]. Consequently,
a ScvO2 of 60 % as interventional threshold could be
considered to be a rather low. However, in pulmonary
resection surgery, the main concern is still the development
Table 1 Basic characteristics
Before group (n = 18) After group (n = 12) p value
Age (years) a 62 (47; 68) 58 (43; 67) 0.19
Gender c 1.00
Female 5 (28) 3 (25)
Male 13 (72) 9 (75)
Weight (kg) b 82 (74; 89) 83 (72; 94) 0.83
Height (cm) b 176 (172; 180) 178 (172; 184) 0.48
BMI > 30 c 2 (11) 2 (17) 1.0
Smoking status c 1.0
Current 4 (22) 2 (17)
Former 7 (39) 5 (41)
Never 6 (33) 5 (42)
Data missing 1 (6) 0
ASA-classification c 1.0
ASA I 1 (6) 0
ASA II 12 (67) 8 (67)
ASA III 5 (28) 4 (33)
Comorbidity c
COPD 0 0
Hypertension 4 (22) 3 (25)
IHD 1 (6) 0
DM 1 (6) 2 (17)
Resection sidec 0.71
Right 8 (44) 7 (58)
Left 10 (56) 5 (42)
TNM-classificationc Pre-operative Postoperative Pre-operative Postoperative
T1N0M0 2 (6) 0 0 0
T2N0M0 12 (67) 3 (17) 9 (75) 1 (8)
T3N0M0 4 (22) 12 (67) 1 (8) 3 (25)
T3N1M0 0 0 0 2 (17)
T3N2M0 0 1 (6) 1 (8) 5 (42)
T4N0M0 0 1 (6) 1 (8) 1 (8)
T4N1M0 0 1 (6) 0 0
Preoperative FEV1b (% of expected) 87 [80; 94] 77 [68; 85] 0.07
Preoperative DLCOb (% of expected) 71 [66; 76] 71 [63; 78] 0.93
ASA American Society of Anesthesiologists; BMI Body Mass Index; cm centimetres; COPD Chronic Obstructive Pulmonary Disease; DLCO Diffusing Capacity for
Carbon Monoxide; DM Diabetes Mellitus; FEV1 Forced Expiratory Volume in one second; IHD Ischemic Heart Disease; kg kilograms; TNM Tumour, Node, Metastasis
International Staging System for Lung Cancer
aMedian (range), bMean (95 % confidence interval), cNumber of patients (group percentage)
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of acute lung injury and ARDS [11], which is why the main
purpose of implementing BGDT was to avoid hypervolemia
by restricting fluid administration without compromising
the circulation and oxygen delivery. Thus, due to the
possible hazardous consequences of hypervolemia in
patients undergoing EPP a relatively low interventional
set point for ScvO2 was chosen. Also, it has been sug-
gested that the optimal interventional threshold values
of ScvO2 are dependent on the study population [17]
which is why future prospective studies are needed to es-
tablish optimal target values of ScvO2 adapted to specific
surgical populations.
Table 2 Volumes of administered fluids and fluid balances during and after extrapleural pneumonectomya
Intra-operative ICU on the day of operation
Before group (n = 18) After group (n = 12) P value Before group (n = 18) After group (n = 12) P value
Red blood cellsb 300 (0; 1200) 0 (0; 600) 0 (0; 600) 0 (0; 300)
Fresh frozen plasmab 0 (0; 600) 0 (0; 600) 0 (0; 600) None
Colloids 950 (500; 1750) 500 (0; 1500) 550 (0; 1500) 500 (0; 1500)
Crystalloids 1150 (500; 2500) 1000 (500; 1500) 1713 (625; 3075) 1513 (325; 1975)
Total volume of administered fluid 2675 (1000; 5350) 1600 (600; 3600) 0.01 2588 (1400; 4925) 1810 (825; 3525) 0.04
Fluid balancesc 779 (−429; 1863) −385 (−2130; 10) 0.0003 176 (−970; 1567) 111 (−419; 287) 0.26
All values are given in ml, as median (range). Colloids are dextran, hydroxyethyl starch or 5 % human albumin. Crystalloids are isotonic solutions of crystalloids
with or without glucose
ICU Intensive Care Unit; ml millilitres
aThirty patients divided in two groups according to whether they had surgery before or after changes in standard therapy, bOne unit = 300 ml, cThe calculations in
both groups included insensible perspiration of 1 ml/kg/hour
Table 3 Data from the intra- and postoperative period in thirty patients undergoing extrapleural pneumonectomy (EPP)
Before group (n = 18) After group (n = 12) P value
Duration of surgery (minutes)a 220 (185; 315) 239 (162; 305) 0.17
Bleeding (millilitres)a 1000 (600; 2400) 1065 (250; 1600) 0.49
Cumulated urine output on the day of surgerya 1810 (1240; 2995) 1528 (945; 2320) 0.01
Values of ScvO2, obtained in the ICU on the day of surgerya, b
Lowest values in the period 61.8 % (42.7; 71.2) 60.2 % (56.6; 74.1) 0.45
Highest values in the period 65.0 % (60.1; 77.0) 70.6 % (62.5; 78.6) 0.05
Needed inopressor therapy in the ICUc 8 (44) d 3 (25)e 0.44
Pulmonary stasis on X-ray POD 1c 1 (6) 3 (25) 0.27
Postoperative complicationsc
Arial Fibrillation 10 (56) 5 (42) 0.71
Plasma Lactate > 2.5 mmol/lf 5 (28) 3 (25) 1.0
Pneumonia 2 (11) 0 0.50
Respiratory insufficiency 1 (6) 0 1.0
Gastrointestinal complicationsg 2 (11) 3 (25) 0.36
Serum Creatinine POD 1 POD 3 POD 1 POD 3
Increased 1.5–2 x preoperative level 0 3 (17) 1 (8) 1 (8) 0.40/0.63
Increased 2–3 x preoperative level 1 (6) 1 (6) 1 (8) 1 (8) 1.00/1.00
Increased more than 3 x preoperative level 0 1 (6) 0 0 –/1.0
Needed haemodialysis or haemofiltration 1 (6) 0 1.0
Readmissions to the ICUf 1 (6) 0 1.0
Thirty days mortalityf 1 (6) 0 1.0
Length of stay in the ICU (days)a 1 (1; 25) 1 (1; 1) 0.04
Length of stay in hospital (days)a 16.5 (8; 42) 13 (10; 24) 0.09
ICU Intensive Care Unit; POD Postoperative Day; ScvO2 Central venous saturation
aMedian (range), bn = 16 in the before group and n = 11 in the after group, c Number of patients (group percentage), dAll 8 patients received continuous infusion
of dopamine between six and 72 h, and one patient needed supplementary infusion of norepinephrine for six hours, eAll three patients received continuous
infusion of dopamine between 10 and 11 h, f Values obtained on the day of operation, gPseudo obstruction or severe constipation
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Attempting to minimize the total expansion of body
interstitial fluids, we wished to restrict the use of crystal-
loids but at the same time avoiding the use of blood
products for volume substitution. Therefore, we changed
the recommended colloid of choice from dextran to
hydroxyethyl starch, allowing administration of a higher
dose in 24 h. We acknowledge that the use of synthetic
colloids is controversial due to results from multicentre
studies on sepsis treatment [19, 20], but similar studies
in surgical patients are still anticipated. Beside the
change of colloid, the new guidelines also clearly empha-
sised the restrictive use of blood products which may
have contributed to the observed tendency towards re-
duced volumes of administered blood products and the
reduced proportion of patients, who received blood
transfusion in the after group. Also, the total volume of
intraoperative fluids were reduced (Table 3) resulting in
less hemodilution.
Radiological signs of pulmonary stasis were present on
chest X-rays from the first POD in one patient from the
before group and in three patients from the after group,
but none of the four patients had clinical symptoms of
pulmonary stasis or oedema, and all were discharged
from the ICU on POD 1. The implementation of BGDT
did not seem to increase the incidence of kidney injury
according to the creatinine criteria of the RIFLE-
classification [21] neither did it increase the use of ino-
tropic agents in the ICU (Table 3).
A limitation to this retrospective, observational study
is that the impact of the changes to standard therapy,
were compared to a group of historical, non-matched
patients and therefore the results could be dependent on
non-measured variables among patients. However, this
group of patients is a highly selected group without sig-
nificant comorbidity and the data were comparable re-
garding basic characteristics, suggesting an acceptable
matching between groups. Furthermore, the main part
of the data was collected from electronic databases,
which might result in a higher level of data validity and
completeness. Another limitation is that several changes
were applied at the same time, which prevents us from
drawing conclusions on the impact of the individual
changes. Also, our results could be influenced by vari-
ables of clinical, technical, or logistic origin that were
not controlled during the study period. Finally, the small
sample size and hereby potential lack of statistically
power precludes us from drawing conclusions on risk
and benefits and therefore our results should be consid-
ered hypothesis generating, serving for designing further
investigations.
Conclusion
In this retrospective study, a number of perioperative
steps to limit fluid administration in patients undergoing
EPP without compromising circulation and oxygen supply
were associated with a reduction in mean LOSI without
increasing the incidence of postoperative complications.
Our results suggests that it may be safe to use simple clin-
ical parameters in guiding fluid therapy in high-risk sur-
gery, but due to methodological limitations these results
are only hypothesis generating.
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